Celexa vs. Viibryd
See how Celexa and Viibryd compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Celexa and Viibryd both treat major depressive disorder in adults and both carry a boxed warning for increased suicidal thoughts in children and young adults.
Celexa is an SSRI with a simple two-week titration and much lower cost, while Viibryd is a SPARI with a three-step titration that must be taken with food.
Both drugs commonly cause nausea and insomnia, but Viibryd causes more diarrhea while Celexa causes more dry mouth and sedation.
Celexa vs. Viibryd Drug Summary
Celexa
Celexa (citalopram) is a selective serotonin reuptake inhibitor (SSRI) approved to treat major depressive disorder in adults. It comes as a tablet or oral solution taken once daily, starting at 20 mg and increasing to a 40 mg maintenance dose after one week. It has been available since 1998 and remains one of the most widely prescribed antidepressants.
Viibryd
Viibryd (vilazodone) is a serotonin partial agonist and reuptake inhibitor (SPARI) approved to treat major depressive disorder in adults. It's taken as a tablet once daily with food, titrated from 10 mg up to a 40 mg maintenance dose over two weeks. Approved in 2011, it works through a mechanism distinct from standard SSRIs.
Celexa vs. Viibryd Side Effects
Celexa
Viibryd
Celexa vs. Viibryd Dosage
Celexa
Viibryd
| STAGE | DOSE | WHEN |
| Starting dose | 20 mg once daily | Week 1 |
| Maximum dose | 40 mg once daily | Week 2 onward |
| Dose changes | 1 increase | Every week |
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | Days 1-7 |
| Maximum dose | 40 mg once daily | Day 15 onward |
| Dose changes | 2 increases | Every 7 days |
Celexa
| STAGE | DOSE | WHEN |
| Starting dose | 20 mg once daily | Week 1 |
| Maximum dose | 40 mg once daily | Week 2 onward |
| Dose changes | 1 increase | Every week |
Viibryd
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | Days 1-7 |
| Maximum dose | 40 mg once daily | Day 15 onward |
| Dose changes | 2 increases | Every 7 days |
Celexa vs. Viibryd Indications
Celexa
Celexa is FDA-approved to treat major depressive disorder in adults. Clinicians also prescribe it off-label for generalized anxiety disorder, panic disorder, and obsessive-compulsive disorder. It is not approved for use in children or for bipolar depression.
FDA-approved for major depressive disorder in adults
Prescribed off-label for generalized anxiety disorder
Prescribed off-label for panic disorder
Prescribed off-label for obsessive-compulsive disorder
Viibryd
Viibryd is FDA-approved to treat major depressive disorder in adults. It has no widely recognized off-label uses and is not approved for pediatric depression. It must be taken with food for the medication to absorb properly.
FDA-approved for major depressive disorder in adults
Not approved for pediatric depression
No established off-label uses at this time
Requires food intake for proper absorption
Celexa vs. Viibryd Pros and Cons
Celexa
Celexa has an established long-term safety profile and is available as a low-cost generic, making it accessible for most patients. Its main clinical limitation is a dose-dependent QT prolongation risk, which caps the maximum dose and requires added caution in older adults. It remains a reasonable first-line choice for straightforward MDD, with off-label usefulness for anxiety-related conditions.
Pros
Available as an inexpensive generic tablet or oral solution
Decades of long-term safety data since its 1998 approval
Reaches full maintenance dose in just two weeks
Prescribed off-label for anxiety, panic disorder, and OCD
Cons
Carries a dose-dependent QT prolongation risk requiring caution
Maximum dose capped at 20 mg/day in older adults or poor metabolizers
Cannot exceed 40 mg/day, limiting dose flexibility
More likely to cause dry mouth and sedation than Viibryd
Viibryd
Viibryd offers a distinct SPARI mechanism that may suit patients who did not respond well to standard SSRIs, along with a milder anticholinergic side effect profile. Its main drawbacks are a longer titration schedule, a strict food requirement for absorption, and a significantly higher cost with no generic option. It functions more as a second-line choice for adults with MDD rather than a typical first pick.
Pros
Lower rates of dry mouth and sedation than Celexa
No dose reduction required based on age or liver function
Distinct SPARI mechanism, an option for SSRI non-responders
No QT-prolongation warning on its label
Cons
Longer three-step titration process before reaching full dose
Must be taken with food or absorption drops significantly
Higher rates of diarrhea and nausea than Celexa
No generic version widely available despite FDA generic approval
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.